balance equationreview2023-09-30
Difference 374817000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$743.17M
Fiscal year ended 2026-06-30Net income
$28.00M
Fiscal year ended 2026-06-30Total assets
$720.33M
Fiscal year ended 2026-06-30CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported revenue of $743.17M and net income of $28.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from CLOVER HEALTH INVESTMENTS, CORP. /DE’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Hospital & Medical Service Plans.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743.17M | $749.19M | $487.71M | $496.65M | $477.62M | $462.33M | $336.96M | $330.99M | $356.26M | $346.92M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $81.21M | $107.91M | $81.76M |
| Operating income | $28.00M | $27.33M | -$49.32M | -$24.38M | -$10.56M | -$1.27M | -$21.45M | -$8.78M | $7.19M | -$22.70M |
| Net income | $28.00M | $27.33M | Unavailable | -$24.38M | -$10.58M | -$1.27M | Unavailable | -$9.16M | $7.41M | -$19.17M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 545.45M | shares 532.50M | Unavailable | shares 512.74M | shares 509.04M | shares 497.06M | Unavailable | shares 490.18M | shares 495.18M | shares 486.37M |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Diluted EPS | $0.05 | $0.05 | Unavailable | Unavailable | $-0.02 | $0.00 | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $70.30M | $74.63M | $66.16M | $48.95M | $48.48M | $50.68M | $52.29M | $35.20M | $44.42M | $44.57M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | $78.30M | Unavailable | Unavailable | Unavailable | $194.54M | $287.96M | $254.77M | $208.26M |
| Total assets | $720.33M | $697.73M | $541.01M | $559.66M | $574.99M | $583.72M | $580.74M | $653.01M | $674.21M | $671.77M |
| Current assets | $485.45M | $448.02M | $307.86M | $330.92M | $362.94M | $331.41M | $343.12M | $432.73M | $549.58M | $552.74M |
| Total liabilities | $344.07M | $358.30M | $232.31M | $218.73M | $230.81M | $247.64M | $239.60M | $310.85M | $349.32M | $379.30M |
| Current liabilities | $323.33M | $336.58M | $208.82M | $193.45M | $201.95M | $215.65M | $213.52M | $279.64M | $324.51M | $356.39M |
| Total equity incl. NCI | $376.26M | $339.43M | $308.70M | $340.93M | $344.18M | $336.08M | $341.14M | $342.17M | $324.89M | $292.47M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $25.19M | $107.90M | -$68.15M | $12.10M | $5.41M | -$16.29M | -$85.83M | $49.99M | $44.76M | $25.94M |
| Capital expenditures | $682.00K | $854.00K | $597.00K | $692.00K | $569.00K | $185.00K | $315.00K | $399.00K | $397.00K | $445.00K |
| Investing cash flow | -$32.00K | -$5.07M | -$35.00M | -$5.42M | $35.57M | $8.93M | -$1.44M | -$12.14M | $4.95M | $9.18M |
| Financing cash flow | $416.00K | -$7.86M | -$8.61M | -$5.27M | -$7.76M | -$31.74M | -$6.14M | -$4.67M | -$3.20M | -$3.36M |
| Net change in cash | $25.57M | $94.96M | -$111.75M | $1.41M | $33.21M | -$39.10M | -$93.41M | $33.18M | $46.52M | $31.76M |
| Stock-based compensation | $9.08M | $12.27M | $24.92M | $26.11M | $26.20M | $26.44M | $29.64M | $27.99M | $27.90M | $28.80M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $0 | $0 | $0 | $1.00K | $0 | $18.30M | $0 | $0 | $1.77M | $0 |
| Depreciation & amortization | $564.00K | $515.00K | $420.00K | $406.00K | $394.00K | $466.00K | -$384.00K | $339.00K | $330.00K | $318.00K |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $24.51M | $107.04M | -$68.75M | $11.41M | $4.84M | -$16.48M | -$86.15M | $49.59M | $44.36M | $25.49M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.4% | -2.7% | 2.0% | -6.5% |
| FCF margin | 3.3% | 14.3% | -14.1% | 2.3% | 1.0% | -3.6% | -25.6% | 15.0% | 12.5% | 7.3% |
| SBC / revenue | 1.2% | 1.6% | 5.1% | 5.3% | 5.5% | 5.7% | 8.8% | 8.5% | 7.8% | 8.3% |
| Current ratio | 1.50x | 1.33x | 1.47x | 1.71x | 1.80x | 1.54x | 1.61x | 1.55x | 1.69x | 1.55x |
| Revenue YoY growth | 55.6% | 62.0% | 44.7% | 50.1% | 34.1% | 33.3% | 7.9% | 8.2% | 11.3% | 7.7% |
| Net margin | 3.8% | Unavailable | Unavailable | -4.9% | -2.2% | Unavailable | Unavailable | -2.8% | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLOV in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2023-06-30
Difference 555982000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2023-03-31
Difference 716104000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.